The global pregabalin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Pregabalin is a medication that is used to treat epilepsy and anxiety. It is also used to treat nerve pain that can be caused by different conditions including diabetes and shingles, or an injury. The major factor driving the demand for the global pregabalin market during the forecast period is the increasing prevalence of epilepsy across the globe. Moreover, the market is also growing due to the growing geriatric population coupled with the increasing prevalence of diabetes as well as neuropathic pain among people globally.
According to the World Health Organization (WHO), in 2019, epilepsy is one of the most common neurological diseases globally with around 50 million people diagnosed with it. Additionally, almost 80% of people with epilepsy live in low and middle-income countries and up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated. However, the risk of mortality is three times higher in people with epilepsy than in the general population. Hence the rising prevalence of epilepsy is driving the demand for pregabalin for treatment which in turn is boosting its market growth.
To Request a Sample of our Report on Pregabalin Market: https://www.omrglobal.com/request-sample/pregabalin-market
Some major players in the market include Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Cipla Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in December 2020, Sawai announced the launch of the first generic version of the Lyrica pregabalin brand in Japan.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Cipla Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Pregabalin Market is Available @ https://www.omrglobal.com/industry-reports/pregabalin-market
Global Pregabalin Market Report by Segment
By Type
- Capsules
- Oral Solutions
- Others
By Application
- Epilepsy
- Neuropathic Pain
- Anxiety Disorder
- Others
Global Pregabalin Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
